International
The Morning Science

What science found today

‹
 

Research

Deubiquitination of C/EBPβ by FAM63A mediates resistance to glutaminolysis inhibition in MYC-amplified hepatocellular carcinoma

Nature ·

The Brief

  • A study reports that FAM63A deubiquitinates C/EBPβ in MYC-amplified hepatocellular carcinoma.
  • The deubiquitination is described as mediating resistance to glutaminolysis inhibition.
  • The article was listed in a nature.com subject feed dated 2026-11-17 with no summary provided.

Why it matters

The work points to a possible mechanism by which MYC-amplified liver cancer cells evade therapies targeting glutamine metabolism, which may inform future drug combination research.

Who’s affected

  • cancer biologists
  • researchers studying liver cancer metabolism

Timeline

  1. Article listed in nature.com subject feed

  2. Biological sciences : nature.com subject feeds

    Deubiquitination of C/EBPβ by FAM63A mediates resistance to glutaminolysis inhibition in MYC-amplified hepatocellular carcinoma

How do you feel about this?

0 Comments

    Deubiquitination of C/EBPβ by FAM63A mediates resistance to glutaminolysis inhibition in MYC-amplified hepatocellular carcinoma – The Morning Science